Literature DB >> 11535246

Human cytosolic sulphotransferases: genetics, characteristics, toxicological aspects.

H Glatt1, H Boeing, C E Engelke, L Ma, A Kuhlow, U Pabel, D Pomplun, W Teubner, W Meinl.   

Abstract

Cytosolic sulphotransferases transfer the sulpho moiety from the cofactor 5'-phosphoadenosine-3'-phosphosulphate (PAPS) to nucleophilic groups of xenobiotics and small endogenous compounds (such as hormones and neurotransmitters). This reaction often leads to products that can be excreted readily. However, other sulpho conjugates are strong electrophiles and may covalently bind with DNA and proteins. All known cytosolic sulphotransferases are members of an enzyme/gene superfamily termed SULT. In humans, 10 SULT genes are known. One of these genes encodes two different enzyme forms due to the use of alternative first exons. Different SULT forms substantially differ in their substrate specificity and tissue distribution. Genetic polymorphisms have been described for three human SULTs. Several allelic variants differ in functional properties, including the activation of promutagens. Only initial results are available from the analysis of SULT allele frequencies in different population groups, e.g. subjects suffering from specific diseases and corresponding controls.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11535246     DOI: 10.1016/s0027-5107(01)00207-x

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  44 in total

1.  In vitro characterization of the human biotransformation pathways of aplidine, a novel marine anti-cancer drug.

Authors:  Esther F A Brandon; Rolf W Sparidans; Ronald D van Ooijen; Irma Meijerman; Luis Lopez Lazaro; Ignacio Manzanares; Jos H Beijnen; Jan H M Schellens
Journal:  Invest New Drugs       Date:  2007-02       Impact factor: 3.850

2.  The use of cellular diagnostics for identifying sub-lethal stress in reef corals.

Authors:  Craig A Downs; Gary K Ostrander; Luc Rougee; Teina Rongo; Sean Knutson; David E Williams; Wendy Mendiola; Jackalyn Holbrook; Robert H Richmond
Journal:  Ecotoxicology       Date:  2012-01-05       Impact factor: 2.823

Review 3.  Contributions of human enzymes in carcinogen metabolism.

Authors:  Slobodan Rendic; F Peter Guengerich
Journal:  Chem Res Toxicol       Date:  2012-05-10       Impact factor: 3.739

Review 4.  Sulfotransferase gene copy number variation: pharmacogenetics and function.

Authors:  S J Hebbring; A M Moyer; R M Weinshilboum
Journal:  Cytogenet Genome Res       Date:  2009-03-11       Impact factor: 1.636

5.  Hydroxylated and sulfated metabolites of commonly occurring airborne polychlorinated biphenyls inhibit human steroid sulfotransferases SULT1E1 and SULT2A1.

Authors:  Victoria S Parker; Edwin J Squirewell; Hans-Joachim Lehmler; Larry W Robertson; Michael W Duffel
Journal:  Environ Toxicol Pharmacol       Date:  2018-02-03       Impact factor: 4.860

6.  Structure-activity relationships for hydroxylated polychlorinated biphenyls as inhibitors of the sulfation of dehydroepiandrosterone catalyzed by human hydroxysteroid sulfotransferase SULT2A1.

Authors:  Edugie J Ekuase; Yungang Liu; Hans-Joachim Lehmler; Larry W Robertson; Michael W Duffel
Journal:  Chem Res Toxicol       Date:  2011-09-28       Impact factor: 3.739

7.  Pharmacogenetics of SULT1A1.

Authors:  Jaclyn Daniels; Susan Kadlubar
Journal:  Pharmacogenomics       Date:  2014-11       Impact factor: 2.533

8.  Androgen deprivation by activating the liver X receptor.

Authors:  Jung Hoon Lee; Haibiao Gong; Shaheen Khadem; Yi Lu; Xiang Gao; Song Li; Jian Zhang; Wen Xie
Journal:  Endocrinology       Date:  2008-05-01       Impact factor: 4.736

9.  Transcriptional Regulation of Human Cytosolic Sulfotransferase 1C3 by Peroxisome Proliferator-Activated Receptor γ in LS180 Human Colorectal Adenocarcinoma Cells.

Authors:  Sarah Dubaisi; Hailin Fang; Thomas A Kocarek; Melissa Runge-Morris
Journal:  Mol Pharmacol       Date:  2016-08-26       Impact factor: 4.436

10.  Regulation of sulfotransferase and UDP-glucuronosyltransferase gene expression by the PPARs.

Authors:  Melissa Runge-Morris; Thomas A Kocarek
Journal:  PPAR Res       Date:  2009-08-10       Impact factor: 4.964

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.